Cited by 1,154Tuberculosis Research and EpidemiologyInfectious Diseases and TuberculosisMycobacterium research and diagnosis

The DOI matches its Crossref record; 322 of the 322 references it cites were found in a registry or an index.

Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence

Open access

Smith, Issar·2003·Clinical Microbiology Reviews

DOI 10.1128/cmr.16.3.463-496.2003PMC PMC164219

Open this paper in CoChat — free account

Abstract

Tuberculosis (TB), one of the oldest known human diseases. is still is one of the major causes of mortality, since two million people die each year from this malady. TB has many manifestations, affecting bone, the central nervous system, and many other organ systems, but it is primarily a pulmonary disease that is initiated by the deposition of Mycobacterium tuberculosis, contained in aerosol droplets, onto lung alveolar surfaces. From this point, the progression of the disease can have several outcomes, determined largely by the response of the host immune system. The efficacy of this response is affected by intrinsic factors such as the genetics of the immune system as well as extrinsic factors, e.g., insults to the immune system and the nutritional and physiological state of the host. In addition, the pathogen may play a role in disease progression since some M. tuberculosis strains are reportedly more virulent than others, as defined by increased transmissibility as well as being associated with higher morbidity and mortality in infected individuals. Despite the widespread use of an attenuated live vaccine and several antibiotics, there is more TB than ever before, requiring new vaccines and drugs and more specific and rapid diagnostics. Researchers are utilizing information obtained from the complete sequence of the M. tuberculosis genome and from new genetic and physiological methods to identify targets in M. tuberculosis that will aid in the development of these sorely needed antitubercular agents.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/cmr.16.3.463-496.2003

Cites

322 of 322 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Molecular Beacons: Probes that Fluoresce upon Hybridization
Tyagi, S., & Kramer, F. R. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-303 · Cited by 4,164
Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)
Bentley, S. D., Chater, K. F., Cerdeño-Tárraga, A. M., Challis, G. L., Thomson, N. R., James, K., Harris, D. E., Quail, M. A., Kieser, H. M., Harper, D., et al. (2002) · Nature · doi:10.1038/417141a · Cited by 3,226
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R. B., Armour, C. D., Bennett, H. A., Coffey, E. M., Dai, H. A., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,534
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
Hoiseth, S. K., & Stocker, B. A. D. (1981) · Nature · doi:10.1038/291238a0 · Cited by 2,088
THE ENVELOPE OF MYCOBACTERIA
Brennan, P. J., & Nikaido, H. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000333 · Cited by 2,045
Massive gene decay in the leprosy bacillus.
Cole, S. T., Eiglmeier, K., Parkhill, J., James, K. D., Thomson, N. R., Wheeler, P. R., Honoré, N., Garnier, T., Churcher, C., Harris, D., et al. (2001) · Nature · doi:10.1038/35059006 · Cited by 1,777
Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors
Brightbill, H. D., Libraty, D. H., Krutzik, S. R., Yang, R., Belisle, J. T., Bleharski, J. R., Maitland, M. L., Norgard, M. V., Plevy, S. E., Smale, S. T., et al. (1999) · Science · doi:10.1126/science.285.5428.732 · Cited by 1,659
A new evolutionary scenario for the Mycobacterium tuberculosis complex
Brosch, R., Gordon, S. V., Marmiesse, M., Brodin, P. M., Buchrieser, C., Eiglmeier, K., Garnier, T., Gutierrez, C., Hewinson, R. G., Kremer, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052548299 · Cited by 1,645
Comparative Genomics of BCG Vaccines by Whole-Genome DNA Microarray
Behr, M. A., Wilson, M. A., Gill, W., Salamon, H., Schoolnik, G. K., Rane, S., & Small, P. M. (1999) · Science · doi:10.1126/science.284.5419.1520 · Cited by 1,527

Show all 322 references

Research works printed but not linked: 14

Butcher P. D. J. A. Mangan and I. M. Monahan. 1998. Intracellular gene expression p. 285-306. In T. Parish and N. G. Stoker (ed.) Mycobacterium tuberculosis protocols. Humana Press Totowa N.J.
Derbyshire, K. M., C. Takacs, and J. Huang. 2000. Using the EZ:TNTMTransposomeTM for transposon mutagenesis in Mycobacterium smegmatis.Epicentre Forum7:1-4.
Friedman L. N. (ed.). 2001. Tuberculosis: current concepts and treatment 2nd ed. CRC Press Inc. Boca Raton Fla.
Garay. S. 1996. Pulmonary tuberculosis. p. 373-412. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
Gomez M. and I. Smith. 2000. Determinants of mycobacterial gene expression p. 111-129. In G. F. Hatfull and W. R. Jacobs Jr (ed.) Molcular genetics of mycobacteria. American Society for Microbiology Washington. D.C.
Haas F. and S. S. Haas. 1996. The origins of Mycobacterium tuberculosis and the notion of its contagiousness p. 3-19. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
Hatfull G. F. and W. R. Jacobs Jr. (ed.). 2000. Molecular genetics of mycobacteria. American Society for Microbiology Washington D.C.
Jagirdar J. and D. ZagZag. 1996. Pathology and insights into pathogenesis of tuberculosis p. 467-491. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
Kamholz S. L. 1996. Pleural tuberculosis p. 483-491. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
Munger J. S. and J. H. A. Chapman. 1996. Tissue destruction by proteases p. 353-361. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
Rom W. N. and S. Garay (ed.). 1996. Tuberculosis. Little Brown and Co. Boston Mass.
Talavera W. R. Miranda K. Lessnau and L. Klapholz. 2001. Extrapulmonary tuberculosis p. 139-190. In L. N. Friedman (ed.) Tuberculosis: current concepts and treatment 2nd ed. CRC Press Inc. Boca Raton Fla.
Tyagi A. K. S. K. D. Gupta and S. Jain. 2000. Gene expression: reporter technologies p. 131-147. In G. F. Hatfull and W. R. Jacobs Jr. (ed.) Molecular genetics of mycobacteria. American Society for Microbiology Washington D.C.
Zugar A. and F. D. Lowy. 1996. Tuberculosis of the brain meninges and the spinal cord p. 541-556. In W. N. Rom and S. Gary (ed.) Tuberculosis. Little Brown and Co. Boston Mass.

Sorted by citations

Items 701–800 of 1,000

Regression-Based Ranking of Pathogen Strains with Respect to Their Contribution to Natural Epidemics
Soubeyrand, S., Tollenaere, C., Haon-Lasportes, E., & Laine, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086591 · Cited by 5
Treatment of chest wall tuberculosis with transdermal ultrasound-mediated drug delivery
Han, Y., Zhao, Q., Yu, D., & Liu, Z. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2219 · Cited by 5
HGV&TB: a comprehensive online resource on human genes and genetic variants associated with tuberculosis
Sahajpal, R., Kandoi, G., Dhiman, H., Raj, S., Scaria, V., Bhartiya, D., & Hasija, Y. (2014) · Database · doi:10.1093/database/bau112 · Cited by 5
Immunophenotypic Characterization of Peripheral Blood T-Lymphocytes and Their Subpopulations in Tuberculosis Patients before and after Treatments.
Pessaran, Z., SahebFosul, F., Oreizi, F., Ghavaminejad, A., Kiani, A., & Siadat, Z. D. (2005) · PubMed · Cited by 5
MYCOBACTERIUM TUBERCULOSIS VIRULENCE
Vishnevsky, B., Manicheva, O. A., & Yаblonskiy, P. K. (2015) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2014-4-319-330 · Cited by 5
Immunoinformatics Prediction of Epitope Based Peptide Vaccine Against Mycobacterium Tuberculosis PPE65 family ProteinPreprint
Elhag, M., Sati, A. O. M., Saadaldin, M. M., & Hassan, M. A. E. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/755983 · Cited by 5
Potential of Nanotechnology-based Formulations in Combating Pulmonary Infectious Diseases: A Current Scenario
Patel, M., Mazumder, R., Mishra, R., & KAUSHIK, K. K. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221116143138 · Cited by 3
Concurrent Sphingomonas paucimobilis and Mycobacterium tuberculosis Meningitis in an Immunocompromised Patient: A Rare Case Report and Comprehensive Review of Literature
Marincu, I., Bratosin, F., Bogdan, I. G., Dumitru, C., Stoica, C. N., Csep, A. N., Mederle, N. G., Fericean, R. M., Mederle, O. A., Prathipati, R., et al. (2023) · Medicina · doi:10.3390/medicina59040687 · Cited by 4
Structure-guided identification and characterization of potent inhibitors targeting PhoP and MtrA to combat mycobacteria
Su, H.-L., Lai, S.-J., Tsai, K., Fung, K.-M., Lung, T.-L., Hsu, H.-M., Wu, Y., Liu, C. Q., Lai, H.-X., Lin, J.-H., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.04.005 · Cited by 5
Revitalizing antimicrobial strategies: paromomycin and dicoumarol repurposed as potent inhibitors of M.tb's replication machinery via targeting the vital protein DnaN
Ali, W., Agarwal, M., Jamal, S., Gangwar, R., Sharma, R., Mubarak, M. M., Wani, Z. A., Ahmad, Z., Khan, A., Sheikh, J. A., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134652 · Cited by 4
Progress in the role of nanoparticles in the diagnosis and treatment of bone and joint tuberculosis
Ding, Y., Li, B., Yi, Y., Liu, C., Wen, J., Jian, X., & Li, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1536547 · Cited by 4
Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis
Wei, M., Bostani, A., Jamalsi, N., Baqin, H., & Wen, P. F. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04422-z · Cited by 4
Cell Wall Biosynthesis and Latency During Tuberculosis Infections
Kurosu, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-25381-3_1 · Cited by 4
Paper-based devices
Aydın, E. B., Aydın, M., & Sezgintürk, M. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818592-6.00006-2 · Cited by 4
Anti-mycobacterial compounds derived from marine organisms: Mode of actions and potential in tuberculosis treatment
Babu, A. S., & Rao, K. V. B. (2021) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2021.029.2.03 · Cited by 4
Association of IRGM promoter region polymorphisms and haplotype with pulmonary tuberculosis in Pakistani (Punjab) population
Zafar, A., Shafiq, M., Ali, B., Sadée, W., Shakoori, A. R., & Shakoori, F. R. (2022) · Tuberculosis · doi:10.1016/j.tube.2022.102233 · Cited by 4
COVID-19 Syndemic: Convergence of COVID-19, Pulmonary Aspergillosis (CAPA), Pulmonary Tuberculosis, Type 2 Diabetes Mellitus, and Arterial Hypertension
Badillo-Almaraz, J. I., Cardenas-Cadena, S. A., Gutierrez-Avella, F. D., Villegas-Medina, P. J., Veloz, I. G., Badillo-Almaraz, V., & Martínez‐Fierro, M. L. (2022) · Diagnostics · doi:10.3390/diagnostics12092058 · Cited by 4
Identification of Anti-Tuberculosis Drugs Targeting DNA Gyrase A and Serine/Threonine Protein Kinase PknB: A Machine Learning-Assisted Drug-Repurposing Approach
Lee, D., Islam, M., Natarajan, S., Dudekula, D., Chung, H.-K., Park, J., & Oh, B. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9120288 · Cited by 2
Bacterial phyla: microbiota of kingdom animalia
Nalage, D. N., Kale, R., Sontakke, T., Pradhan, V., Biradar, A., Senevirathna, J. D. M., Jaweria, D. R., Dighe, T., Dixit, P. K., Patil, R., et al. (2024) · Academia Biology · doi:10.20935/acadbiol7423 · Cited by 5
A novel peptide interferes with Mycobacterium tuberculosis virulence and survival
Samuchiwal, S. K., Tousif, S., Singh, D. K., Kumar, A., Ghosh, A., Bhalla, K., Prakash, P., Kumar, S., Trivedi, A. C., Bhattacharyya, M., et al. (2014) · FEBS Open Bio · doi:10.1016/j.fob.2014.08.001 · Cited by 4
Adaptive changes in gene expression of Mycobacterium tuberculosis during the development of the infection
Skvortsov, T., & Azhikina, T. L. (2012) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162012040139 · Cited by 4
Interaction of Nanoparticles in Biological Systems and their Role in Therapeutical Treatment of Tuberculosis and Cancer
Meena, J., Singh, M. P., Sahare, P., & Meena, L. S. (2014) · Journal of Luminescence and Applications · doi:10.7726/jla.2014.1002 · Cited by 4
Immune responses elicited by the recombinant Erp, HspR, LppX, MmaA4, and OmpA proteins from Mycobacterium tuberculosis in mice
Okay, S., Çetin, R., Karabulut, F., Doğan, C., Sürücüoğlu, S., & Kurt‐Kızıldoğan, A. (2018) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.65.2018.048 · Cited by 4
Manipulation of autophagy for host-directed tuberculosis therapy
Gina, P., Davids, M., & Dheda, K. U. J. (2019) · African Journal of Thoracic and Critical Care Medicine · doi:10.7196/sarj.2019.v25i2.014 · Cited by 4
Cloning and Protein Expression of eccB 5 Gene in ESX-5 System from Mycobacterium tuberculosis
Kurniawati, S., Mertaniasih, N. M., Ato, M., Tamura, T., Soedarsono, S., Aulanni’am, A., Mori, S., Maeda, Y., & Mukai, T. (2020) · BioResearch open access · doi:10.1089/biores.2019.0019 · Cited by 4
Asymptomatic peritoneal tuberculosis in a patient with a non-remitting fever and isolated pulmonary symptoms: a case report and literature review
Ahmadi, F., Tapper, L., Al‐Obudi, Y., Khamar, R., & Khurram, R. (2021) · Radiology Case Reports · doi:10.1016/j.radcr.2021.04.010 · Cited by 4
Deterministic and stochastic in-host tuberculosis models for bacterium-directed and host-directed therapy combination
Zhang, W. (2022) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqac001 · Cited by 4
Metabolic Perspectives on Persistence
Hartman, T. E., Wang, Z., Jansen, R. S., Gardete, S., & Rhee, K. Y. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch31 · Cited by 5
Balancing between apoptosis and survival biomarkers in the patients with tuberculous meningitis.
Kalita, J., Shukla, R., Pandey, P. C., & Misra, U. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155960 · Cited by 3
Scope of using hollow fibers as a medium for drug delivery
Vohra, A., Raturi, P., & Hussain, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96117-2.00013-3 · Cited by 4
Mycobacterial Regulatory Systems Involved in the Regulation of Gene Expression Under Respiration-Inhibitory Conditions
Oh, Y., Lee, H., Ko, E.-M., Jeong, J.-A., Park, S. W., & Oh, J. (2023) · The Journal of Microbiology · doi:10.1007/s12275-023-00026-8 · Cited by 5
Multi-purpose prototypes for extrapulmonary Mycobacterium tuberculosis targeting: A regenerative medicine perspective
Mphaphuli, M. T., Sithole, M. N., Kumar, P., Kondiah, P. P. D., Mabrouk, M., & Choonara, Y. E. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105039 · Cited by 4
Associations Between Socio-Environmental Determinants and the Risk of Pulmonary Tuberculosis in Guilan, Iran
Taher-Ghasemi, Y., Nikokar, I., Yazdanbakhsh, A., Ebrahim‐Saraie, H. S., Sadeghi, R. V., & Rajabi, A. (2016) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.30217 · Cited by 5
Biologically active compounds from natural and marine natural organisms with antituberculosis, antimalarial, leishmaniasis, trypanosomiasis, anthelmintic, antibacterial, antifungal, antiprotozoal, and antiviral activities
Asif, M. (2016) · TANG [HUMANITAS MEDICINE] · doi:10.5667/tang.2014.0017 · Cited by 4
Detection by death: A rapid way to detect viable slow-growing microorganisms achieved using microchannel Electrical Impedance Spectroscopy (m-EIS)
Kargupta, R., Yang, Y., Puttaswamy, S., Lee, A. J., Padilla, N. A., Foutch, A. P., & Sengupta, S. (2018) · TECHNOLOGY · doi:10.1142/s2339547818500012 · Cited by 4
Cell Wall Hydrolytic Enzymes Enhance Antimicrobial Drug Activity Against Mycobacterium
Gustine, J. N., Au, M. B., Haserick, J. R., Hett, E. C., Rubin, E. J., Gibson, F. C., & Deng, L. L. (2019) · Current Microbiology · doi:10.1007/s00284-018-1620-z · Cited by 5
Factors Associated with Mortality in Tuberculosis Patients at Debre Birhan Referral Hospital, Ethiopia: A Retrospective Study
Woldeamanuel, G. G., & Mingude, A. B. (2018) · Journal of Tropical Diseases · doi:10.4172/2329-891x.1000289 · Cited by 3
Cryptic Disseminated Tuberculosis: a Secondary Analysis of Previous Hospital-Based Study.
Khan, F. Y. (2020) · PubMed Central · Cited by 4
Potential Application of Silver Nanocomposites for Antimicrobial Activity
Haque, S., Julappagari, M., & Patra, C. R. (2021) · Materials horizons · doi:10.1007/978-981-33-4753-3_5 · Cited by 4
Unique C-terminal extension and interactome of Mycobacterium tuberculosis GlmU impacts its in vivo function and the survival of the pathogen
Agarwal, M., Soni, V., Kumar, S., Singha, B., & Nandicoori, V. K. (2021) · Biochemical Journal · doi:10.1042/bcj20210170 · Cited by 4
Non-odontogenic Bacterial Infections
Frydrych, A. M., & Farah, C. S. (2019) · Springer eBooks · doi:10.1007/978-3-319-72303-7_46 · Cited by 4
Recent trends in the development of bacterial and fungal vaccines
Mir, M. A., Usman, M., Qadri, H., & Aisha, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00003-6 · Cited by 4
Evaluation of Saraca asoca for its Anti‐Tubercular Potential via Molecular Docking and Molecular Dynamics Simulation Studies
Maurya, S., Jain, A., Singh, V., Haque, S., & Mishra, B. N. (2023) · ChemistrySelect · doi:10.1002/slct.202204899 · Cited by 4
Role of phospholipase C in pathogenesis of Beijing and Non-Beijing strains of Mycobacterium tuberculosis
Goudarzi, H. (2012) · African Journal of Microbiology Research · doi:10.5897/ajmr11.1353 · Cited by 4
Disruption of the gene encoding for secretion antigen SA5K affects growth of Mycobacterium bovis bacillus Calmette-Guérin in human macrophages and in mice
Bottai, D., Esin, S., Batoni, G., Pardini, M., Maisetta, G., Donati, V. L., Favilli, F., Florio, W., & Campa, M. (2004) · Research in Microbiology · doi:10.1016/j.resmic.2004.11.002 · Cited by 4
A multiplex PCR method for detection of Aspergillus spp. and Mycobacterium tuberculosis in BAL specimens
Amini, F., Kachuei, R., Noorbakhsh, F., & Fooladi, A. A. I. (2015) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2015.02.041 · Cited by 4
Immunopathology of Tuberculosis
Actor, J. K., Hunter, R. L., & Jagannath, C. (2008) · Molecular pathology library · doi:10.1007/978-0-387-72430-0_40 · Cited by 4
Glycation of calmodulin binding domain of iNOS may increase the chance of occurrence of tuberculosis in chronic diabetic state
Bhattacharyya, R., & Banerjee, D. (2011) · Bioinformation · doi:10.6026/97320630007324 · Cited by 4
The SecB-like chaperone Rv1957 fromMycobacterium tuberculosis: crystallization and X-ray crystallographic analysis
Lu, Z., Wang, H., & Yu, T. (2016) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x16007287 · Cited by 4
Workplace pulmonary tuberculosis case detection in Mansoura City and neighborhood villages
El-Hadidy, S. S., El-Bestar, S. F., Kamel, E. A., & Shalabi, N. M. (2018) · Egyptian Journal of Bronchology · doi:10.4103/ejb.ejb_54_17 · Cited by 4
Advanced integrative sensing technologies for detection of drug-resistant tuberculosis in point-of-care settings
Paul, A., Dutta, N., Moschou, D. C., & Dutta, G. (2020) · Sensors International · doi:10.1016/j.sintl.2020.100036 · Cited by 4
Antitubercular Activity of 7-Methyljuglone-Loaded Poly-(Lactide Co-Glycolide) Nanoparticles
Diedericks, B., Reid, A.-M., Mandiwana, V., Gordhan, B. G., Kana, B. D., Ray, S. S., & Lall, N. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111477 · Cited by 3
Synthetic Strategies and Biological Activities of Teixobactin and its Analogs: A Review
Kumari, D., & Nagendra, G. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266344835241125074030 · Cited by 3
6-Phenoxyl-4-aminoquinoline: synthesis and preliminary antitubercular-structure activity relationship analyses
Beteck, R. M., Legoabe, L. J., Dube, P. S., Jordaan, A., & Warner, D. F. (2025) · Medicinal Chemistry Research · doi:10.1007/s00044-025-03402-8 · Cited by 3
Tuberculosis treatment outcomes and their related factors in patients with tuberculosis treated at the Antituberculosis Center of Brazzaville, Republic of Congo
Ngouama, B. B., Mouzinga, F. H., Dello, M. N. M., Djontu, J. C., Assiana, D. O. E., Okombi, F. H. O., Tchuandom, S. B., Ayet, M. I., Siele, L. K., Vouvoungui, J. C., et al. (2025) · IJID Regions · doi:10.1016/j.ijregi.2025.100647 · Cited by 3
PPE18 protein of Mycobacterium tuberculosis functions as a virulence factor and is a potential novel therapeutic target
Manikoth, A. G., Sontyana, B., Shrivastava, R., Ghosh, S. K., & Mukhopadhyay, S. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf146 · Cited by 3
Development of machine learning models to identify potentially active compounds against tuberculosis
Rawat, A., Gupta, S., Pal, C., & Chowdhury, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-04668-z · Cited by 4
Analytics for In Silico Development of Inhibitors from Neem (Azadirachta Indica) Against Pantothenate Synthetase of Mycobacterium Tuberculosis
Mahanta, S., Gogoi, B., & Tanti, B. (2020) · Advances in intelligent systems and computing · doi:10.1007/978-981-15-5619-7_11 · Cited by 3
A cytoprotective role for optineurin during mycobacterial infection of macrophages
Ramachandran, G., Yeruva, C. V., Swarup, G., & Raghunand, T. R. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101672 · Cited by 3
Assessment of Psychiatric Illness among Pulmonary Tuberculosis Patients at a Tertiary Care Center in India
Yadav, P., Gupta, A. K., Gautam, A. K., Arya, S., Kumar, A., Mishra, A. K., & Gupta, S. (2024) · Annals of African Medicine · doi:10.4103/aam.aam_18_24 · Cited by 3
Phosphorylation at the D56 residue of MtrA in Mycobacterium tuberculosis enhances its DNA binding affinity by modulating inter-domain interaction
Nayak, S. S., & Krishna, R. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108222 · Cited by 3
Convergence of host immune mechanisms in Mycobacterium tuberculosis pathogenesis
Chandra, R. (2014) · InTech eBooks · doi:10.5772/58319 · Cited by 2
DNA fingerprinting and drug resistance patterns of active pulmonary Mycobacterium tuberculosis in Mansoura hospitals, Egypt
Aal, A. M. A., Agha, S., Zaghloul, M. H. E., Elshahawy, H. A., Azim, D. M. A., & Fathy, A. (2014) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2014.01.014 · Cited by 3
MYCOBACTERIUM TUBERCULOSIS BIOLOGICAL PROPERTIES AND CHARACTERISTICS OF THE INFLAMMATORY REACTION IN PATIENTS WITH INFILTRATIVE PULMONARY TUBERCULOSIS
Титаренко, О. Т., Dyakova, M., Manicheva, O. A., Esmedlyaeva, D. S., Догонадзе, М. З., Alexeyeva, N. P., Perova, T., & Мельникова, Н. Н. (2014) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2014-3-221-228 · Cited by 3
Mycobacterium tuberculosis Chaperonin 60 Paralogues Contribute to Virulence in Tuberculosis
Stokes, R. W. (2013) · Heat shock proteins · doi:10.1007/978-94-007-6787-4_8 · Cited by 3
Ocular tuberculosis: Clinicopathologic assortment and diagnostic challenges
Priyatam, K., & Ranju, K. (2019) · Journal of Clinical Research and Ophthalmology · doi:10.17352/2455-1414.000057 · Cited by 5
Gene mutations related to rifampin resistance of tuberculosis in northwest of Iran
Gholizadeh, P., Pourlak, T., Asgharzadeh, M., Barhaghi, M. H. S., Taghizadeh, S., Rezaee, M. A., Zarei, A., Soltani, E., Hosseinpour, R., & Kafil, H. S. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100672 · Cited by 3
Applications of Microbes in Antibiotics
Cobongela, S. Z. Z. (2022) · Environmental and microbial biotechnology · doi:10.1007/978-981-16-2225-0_25 · Cited by 3
Application of biosurfactants in the treatment of Mycobacterium tuberculosis infection
Sangwan, N., Chauhan, A., & Avti, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85146-6.00005-x · Cited by 3
Klf10 favorsMycobacterium tuberculosissurvival by impairing IFN-γ production and preventing macrophages reprograming to macropinocytosis
Madrid-Paulino, E., Mata‐Espinosa, D., León‐Contreras, J. C., Serrano‐Fujarte, I., de León‐Guerrero, S. D., Villaseñor, T., Ramón‐Luing, L. A., Puente, J. L., Chávez‐Galán, L., Hernández‐Pando, R., et al. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ma0422-288r · Cited by 3
Tuberculous peritonitis post orchiectomy for testicular tuberculosis; a case report and literature review
Tahaineh, S., Mughli, R. A., Seetan, K. I., Alriyalat, S., & Agahi, D. (2023) · Radiology Case Reports · doi:10.1016/j.radcr.2022.12.011 · Cited by 3
Morphological and genomic characteristics of two novel actinomycetes, Ornithinimicrobium sufpigmenti sp. nov. and Ornithinimicrobium faecis sp. nov. isolated from bat faeces (Rousettus leschenaultia and Taphozous perforates)
Huang, Y., Zhang, S., Tao, Y., Yang, J., Lu, S., Jin, D., Pu, J., Luo, W., Zheng, H., Liu, L., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1093407 · Cited by 3
TBC and COVID: an interplay between two infections
Murdaca, G., Paladin, F., Mangini, G., Tiso, D., & Gangemi, S. (2023) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2023.2205638 · Cited by 3
Mycobacterium Tubercular Mediated Inflammation and Lung Carcinogenesis: Connecting Links
Vashishth, A., Shuaib, M., Bansal, T., & Kumar, S. (2023) · OBM Genetics · doi:10.21926/obm.genet.2302183 · Cited by 4
A Rational Approach To Antitubercular Drug Design: Molecular Docking, Prediction of ADME Properties and Evaluation of Antitubercular Activity of Novel Isonicotinamide Scaffold
Das, P., Gumma, S. R., Nayak, A., Menghani, S., Mandhadi, J. R., & Prabhu, P. P. (2023) · Recent Advances in Anti-Infective Drug Discovery · doi:10.2174/2772434418666230710142852 · Cited by 3
Effect of Host Cholesterol on the Membrane Dynamics of Outer Membrane Lipids of Mycobacteria
Adhyapak, P., Liang, K., Duan, M., & Kapoor, S. (2023) · Chemistry - An Asian Journal · doi:10.1002/asia.202300697 · Cited by 3
Temporal Profiling of Host Proteome against Different M. tuberculosis Strains Reveals Delayed Epigenetic Orchestration
Babele, P., Midha, M. K., Rao, K. V. S., & Kumar, A. (2023) · Microorganisms · doi:10.3390/microorganisms11122998 · Cited by 3
Potassium ion channel Kir2.1 negatively regulates protective responses to Mycobacterium bovis BCG
Sinha, V., Singh, A., Singh, A., Saraswati, S. S. K., Rana, A. K., Kalra, K., & Natarajan, K. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae068 · Cited by 3
Transcriptome analysis and molecular characterization of novel small RNAs in Mycobacterium tuberculosis Lineage 1
Jumat, M. I., & Chin, K. L. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-04089-6 · Cited by 3
Anti-Mycobacterial Activity of Bacterial Topoisomerase Inhibitors with Dioxygenated Linkers
Mitton‐Fry, M. J., Cummings, J. E., Lu, Y., Armenia, J. F., Byl, J. A. W., Oviatt, A. A., Bauman, A., Robertson, G. T., Osheroff, N., & Slayden, R. A. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00743 · Cited by 3
SINGLE NUCLEOTIDE POLYMORPHISM OF ECCB5GENEOF MYCOBACTERIUM TUBERCULOSIS COMPLEX ISOLATES FROM SUSPECTED PULMONARY TB PATIENTS IN SURABAYA INDONESIA
Kurniawati, S., Soedarsono, S., Aulanni’am, A., & Mertaniasih, N. M. (2018) · African Journal of Infectious Diseases · doi:10.21010/ajid.v12i2.6 · Cited by 3
Stability preserving non-standard finite difference schemes for diabetes with tuberculosis infectious model
Danumjaya, P., & Dhara, M. (2019) · Letters in Biomathematics · doi:10.1080/23737867.2019.1618743 · Cited by 3
Natural products encompassing antituberculosis activities
Monga, A., & Sharma, A. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-817903-1.00009-7 · Cited by 3
Population Dynamics of Bacterial Pathogens
Maiden, M. C. J., & Urwin, R. (2014) · ASM Press eBooks · doi:10.1128/9781555815622.ch3 · Cited by 3
Системы генов и белков, влияющих на вирулентность микобактерий, и участие их гомологов в осуществлении конъюгации уMycobacterium smegmatis
Prozorov, A. A., Зайчикова, М. В., & Даниленко, В. Н. (2013) · Генетика · doi:10.7868/s0016675813010098 · Cited by 3
In silico identification of common epitopes from pathogenic mycobacteria
Ramírez, B. D. L. C. A., González, R. M., Calero, R., Mirabal, M., Ramı́rez, J. C., Sarmiento, M. E., Norazmi, M. N., & Acosta, A. (2013) · BMC Immunology · doi:10.1186/1471-2172-14-s1-s6 · Cited by 3
The role of transcriptional regulation in maintaining the availability of mycobacterial adenylate cyclases
Casey, S. J., Ford, M. J., & Gazdik, M. A. (2014) · PeerJ · doi:10.7717/peerj.298 · Cited by 3
Regulation of the Immune Response by Mycobacterium tuberculosis Beijing Genotype
Campillo-Navarro, M., Wong‐Baeza, I., Serafn-Lpez, J., Hernández‐Pando, R., Estrada-Parra, S. A., Estrada‐García, I., & Chacón‐Salinas, R. (2015) · InTech eBooks · doi:10.5772/59609 · Cited by 2
Comprehensive Evaluation Of Patient Characteristics And Clinical Parameters As A Diagnostic Aid In Tuberculosis
(2012) · The Internet Journal of Laboratory Medicine · doi:10.5580/2bd7 · Cited by 3
Novel Quantitative PET Imaging Techniques in Tuberculosis
Deogaonkar, V., Khangembam, B. C., Seraj, S. M., Alavi, A. A., Kumar, R., Vangu, M.-D.-T., & Bisson, G. P. (2020) · PET Clinics · doi:10.1016/j.cpet.2019.11.010 · Cited by 3
Influence of NOD-like receptor 2 gene polymorphisms on muramyl dipeptide induced pro-inflammatory response in patients with active pulmonary tuberculosis and household contacts
Mandala, J. P., Thada, S., Sivangala, R., Ponnana, M., Myakala, R., & Gaddam, S. (2021) · Immunobiology · doi:10.1016/j.imbio.2021.152096 · Cited by 3
Potential of Curcumin Nanoparticles in Tuberculosis Management
Das, B. S., Sarangi, A., & Bhattacharya, D. (2021) · Springer eBooks · doi:10.1007/978-981-16-2516-9_13 · Cited by 3
Mycobacterial Genomes
Alexander, D. C., & Liu, J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-152-9_9 · Cited by 3
Gene Replacement Systems
Stoker, N. G., Sander, P., & Reyrat, J. (2004) · doi:10.1128/9781555817657.ch12 · Cited by 3
Tuberculose pulmonar: aumento da eficiência diagnóstica pela associação de métodos microbiológicos e imunológicos para pesquisa de anticorpos IgG anti - Mycobacterium tuberculosis por Western blotting e interferon-gama
Kanunfre, K. A. (2007) · doi:10.11606/t.5.2007.tde-24012008-143132 · Cited by 3
In silico analysis of subcellular localization of putative proteins of Mycobacterium tuberculosis H37Rv strain
Somvanshi, P., Singh, V., & Seth, P. K. (2007) · The Internet Journal of Health · Cited by 3
Tuberculosis
Dheda, K. U. J., Tomasicchio, M., Reuter, A., Davids, M., Calligaro, G., Furin, J. J., van Helden, P. D., Warren, R. M., & Scriba, T. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00248-1 · Cited by 3
Unlocking new ways to tackle tuberculosis using CRISPR-Cas as a potent weapon
Katoch, P., Sharma, A., Gohan, S., Singh, G., & Shrivastava, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91808-4.00004-3 · Cited by 3
Improved metagenome assemblies through selective enrichment of bacterial genomic DNA from eukaryotic host genomic DNA using ATAC-seq
Cantin, L. J., Hotopp, J. C. D., & Foster, J. M. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1352378 · Cited by 2
Usnic acid impacts energy production and iron metabolism in Mycobacterium tuberculosis H37Rv
Sawicki, R., ZABOST, A. T., Jankowski, G., AUGUSTYNOWICZ-KOPEĆ, E. M., Truszkiewicz, W., & Sieniawska, E. (2025) · mSystems · doi:10.1128/msystems.00256-25 · Cited by 2

Authors: Smith, I.
Affiliations: International Center for Public Health (US)
Corresponding author: Smith, Issar
Venue: Clinical Microbiology Reviews
Publisher: American Society for Microbiology
Published: 2003-07
Volume: 16
Issue: 3
Pages: 463-496
ISSN: 0893-8512 (ISSN-L)
1098-6618
DOI: 10.1128/cmr.16.3.463-496.2003
PMC: PMC164219
OpenAlex: W2157638040
Cited by: 1,154
References: 322
Citations by year: 2026: 29 · 2025: 56 · 2024: 57 · 2023: 87 · 2022: 87 · 2021: 87 · 2020: 84 · 2019: 76 · 2018: 73 · 2017: 54 · 2016: 57 · 2015: 54 · 2014: 46 · 2013: 54 · 2012: 33
FWCI: 3.73
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical Microbiology Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Heart, Lung, and Blood Institute (R01 HL 68513, R01HL064544, R01 HL 64544, R01HL068513)
National Institute of Allergy and Infectious Diseases (R01 AI 48856, R01AI048856)
Topics: Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
Keywords: Mycobacterium tuberculosis, tuberculosis pathogenesis, bacterial virulence factors, host immune response, pulmonary tuberculosis, transmissibility, host genetics, host nutritional status, tuberculosis vaccine, tuberculosis drug targets, tuberculosis diagnosis
MeSH terms: Animals, Antitubercular Agents, Disease Models, Animal, Humans, Macrophages, Mycobacterium tuberculosis, Transcription, Genetic, Tuberculosis, Virulence, Genome, Bacterial, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks